About Policlinica Privada Instituto de Medicina Nuclear
Clinical Trials at Policlinica Privada Instituto de Medicina Nuclear
During the past decade, Policlinica Privada Instituto de Medicina Nuclear conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinica Privada Instituto de Medicina Nuclear"
#1 collaborator was "CIMAB (Cuba)" with 1 trials as a collaborator, "Eurofarma Laboratorios S.A." with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator and "Laboratorio Elea Phoenix S.A." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Policlinica Privada Instituto de Medicina Nuclear
According to Clinical.Site data, the most researched conditions in "Policlinica Privada Instituto de Medicina Nuclear" are
"Breast Cancer" (2 trials), "Cancer" (1 trials), "Lung Cancer, Non-small Cell" (1 trials), "NSCLC" (1 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Policlinica Privada Instituto de Medicina Nuclear" in a lesser frequency.
Clinical Trials Intervention Types at Policlinica Privada Instituto de Medicina Nuclear
Most popular intervention types in "Policlinica Privada Instituto de Medicina Nuclear" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "docetaxel" (2 trials), "Best Support Treatment" (1 trials), "CAF regimen" (1 trials), "CMF regimen" (1 trials) and "NPI-2358 + docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Policlinica Privada Instituto de Medicina Nuclear
The vast majority of trials in "Policlinica Privada Instituto de Medicina Nuclear" are
3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Policlinica Privada Instituto de Medicina Nuclear
Currently, there are NaN active trials in "Policlinica Privada Instituto de Medicina Nuclear".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Policlinica Privada Instituto de Medicina Nuclear,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Policlinica Privada Instituto de Medicina Nuclear, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".